217 related articles for article (PubMed ID: 808229)
1. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
Ruddy S; Fearon DT; Austen KF
Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
[TBL] [Abstract][Full Text] [Related]
2. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
Perrin LH; Nydegger UE; Zubler RH; Lambert PH; Miescher PA
Arthritis Rheum; 1977 Mar; 20(2):647-52. PubMed ID: 849359
[TBL] [Abstract][Full Text] [Related]
3. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
5. Activation of the complement and properdin systems in rheumatoid arthritis.
Ruddy S; Austen KF
Ann N Y Acad Sci; 1975 Jun; 256():96-104. PubMed ID: 1099964
[TBL] [Abstract][Full Text] [Related]
6. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
7. Behaviour of synovial complement C3 and C4 components in inflammatory and degenerative joint diseases, before and after synoviorthesis.
Gabay R; Micheli A; Fallet GH
Ann Rheum Dis; 1975 Apr; 34(2):166-70. PubMed ID: 806271
[TBL] [Abstract][Full Text] [Related]
8. Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.
Mellbye OJ; Naes B; Munthe E
Ann Rheum Dis; 1976 Jun; 35(3):233-9. PubMed ID: 825053
[TBL] [Abstract][Full Text] [Related]
9. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
10. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex.
Mollnes TE; Lea T; Mellbye OJ; Pahle J; Grand O; Harboe M
Arthritis Rheum; 1986 Jun; 29(6):715-21. PubMed ID: 3718564
[TBL] [Abstract][Full Text] [Related]
11. Intraarticular activation of the complement system in patients with juvenile rheumatoid arthritis.
Rynes RI; Ruddy S; Spragg J; Stillman JS; Austen KF
Arthritis Rheum; 1976; 19(2):161-8. PubMed ID: 1259792
[TBL] [Abstract][Full Text] [Related]
12. Alternative pathway complement activation in rheumatoid arthritis.
El-Ghobarey A; Whaley K
J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
[TBL] [Abstract][Full Text] [Related]
13. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
[TBL] [Abstract][Full Text] [Related]
14. Evidence for complement activation by the alternate pathway in the arthritis of hypogammaglobulinemic patients.
Munthe E; Hoyeraal HM; Froland SS; Mellbye OJ; Kåss E; Natvig JB
Rheumatology; 1975; 6():43-51. PubMed ID: 1081730
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins.
Lu-Steffes M; Iammartino AJ; Schmid FR; Castor CW; Davis L; Entwistle R; Anderson B
Ann Clin Lab Sci; 1982; 12(3):178-85. PubMed ID: 7092168
[TBL] [Abstract][Full Text] [Related]
16. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
[TBL] [Abstract][Full Text] [Related]
17. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
Perrin LH; Shiraishi S; Stroud RM; Lambert PH
J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the immunological tests in rheumatoid arthritis.
Kim NH; Yang KH; Yang IH
Yonsei Med J; 1989; 30(1):23-9. PubMed ID: 2741472
[TBL] [Abstract][Full Text] [Related]
19. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
20. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
Stojan B
Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
